Ameriprise’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-284,995
Closed -$4.38M 4109
2025
Q4
$4.38M Sell
284,995
-11,348
-4% -$125K ﹤0.01% 2531
2025
Q3
$2.94M Sell
296,343
-37,994
-11% -$395K ﹤0.01% 2777
2025
Q2
$3.32M Sell
334,337
-34,632
-9% -$365K ﹤0.01% 2659
2025
Q1
$4.79M Sell
368,969
-28,133
-7% -$372K ﹤0.01% 2350
2024
Q4
$5.07M Sell
397,102
-16,176
-4% -$196K ﹤0.01% 2341
2024
Q3
$4.6M Sell
413,278
-37,462
-8% -$413K ﹤0.01% 2430
2024
Q2
$5.06M Sell
450,740
-12,641
-3% -$147K ﹤0.01% 2301
2024
Q1
$5.75M Buy
463,381
+72,397
+19% +$944K ﹤0.01% 2264
2023
Q4
$5.47M Sell
390,984
-25,893
-6% -$360K ﹤0.01% 2284
2023
Q3
$6.16M Sell
416,877
-9,481
-2% -$133K ﹤0.01% 2122
2023
Q2
$5.51M Sell
426,358
-13,627
-3% -$155K ﹤0.01% 2273
2023
Q1
$4.32M Sell
439,985
-22,665
-5% -$242K ﹤0.01% 2417
2022
Q4
$4.92M Sell
462,650
-18,665
-4% -$217K ﹤0.01% 2310
2022
Q3
$5.03M Sell
481,315
-19,557
-4% -$255K ﹤0.01% 2220
2022
Q2
$6.3M Buy
+500,872
New +$5.32M ﹤0.01% 2096
2022
Q1
Sell
-21,206
Closed -$298K 3961
2021
Q4
$298K Sell
21,206
-4,867
-19% -$80.1K ﹤0.01% 3675
2021
Q3
$501K Sell
26,073
-7,581
-23% -$101K ﹤0.01% 3406
2021
Q2
$333K Buy
33,654
+818
+2% +$7.44K ﹤0.01% 3600
2021
Q1
$323K Sell
32,836
-1,283,960
-98% -$10.6M ﹤0.01% 3569
2020
Q4
$5.85M Sell
1,316,796
-788,572
-37% -$3.57M ﹤0.01% 2164
2020
Q3
$9.08M Buy
2,105,368
+885,052
+73% +$6.31M ﹤0.01% 1623
2020
Q2
$10.8M Buy
1,220,316
+1,115,439
+1,064% +$5.64M ﹤0.01% 1486
2020
Q1
$369K Sell
104,877
-701,616
-87% -$3.25M ﹤0.01% 3231
2019
Q4
$4.61M Buy
806,493
+236,561
+42% +$1.26M ﹤0.01% 2286
2019
Q3
$2.04M Sell
569,932
-476,490
-46% -$1.85M ﹤0.01% 2686
2019
Q2
$4.17M Buy
1,046,422
+312,090
+42% +$1.81M ﹤0.01% 2345
2019
Q1
$5.37M Buy
734,332
+153,039
+26% +$1.5M ﹤0.01% 2174
2018
Q4
$5.32M Buy
581,293
+91,330
+19% +$1.01M ﹤0.01% 2084
2018
Q3
$6.08M Buy
489,963
+111,780
+30% +$1.51M ﹤0.01% 2216
2018
Q2
$5.77M Sell
378,183
-63,758
-14% -$1.1M ﹤0.01% 2148
2018
Q1
$8.77M Sell
441,941
-4,293
-1% -$74.1K ﹤0.01% 1767
2017
Q4
$8.35M Sell
446,234
-151,756
-25% -$3.05M ﹤0.01% 1750
2017
Q3
$12.9M Sell
597,990
-289,282
-33% -$4.58M 0.01% 1376
2017
Q2
$8.56M Sell
887,272
-88,010
-9% -$572K ﹤0.01% 1681
2017
Q1
$5.8M Sell
975,282
-1,186
-0.1% -$5.7K ﹤0.01% 1917
2016
Q4
$3.86M Buy
976,468
+139,420
+17% +$1.02M ﹤0.01% 2250
2016
Q3
$8.78M Sell
837,048
-17,513
-2% -$252K ﹤0.01% 1565
2016
Q2
$12.5M Sell
854,561
-10,587
-1% -$181K 0.01% 1234
2016
Q1
$16.6M Buy
865,148
+263,148
+44% +$5.32M 0.01% 1036
2015
Q4
$14.5M Buy
602,000
+30,574
+5% +$766K 0.01% 1156
2015
Q3
$14M Sell
571,426
-77,487
-12% -$2.19M 0.01% 1185
2015
Q2
$15.2M Buy
648,913
+201,930
+45% +$4.4M 0.01% 1223
2015
Q1
$10M Sell
446,983
-70,942
-14% -$1.36M 0.01% 1554
2014
Q4
$8.73M Buy
517,925
+326,167
+170% +$4.97M 0.01% 1617
2014
Q3
$2.74M Sell
191,758
-10,717
-5% -$154K ﹤0.01% 2371
2014
Q2
$3.24M Sell
202,475
-9,762
-5% -$147K ﹤0.01% 2314
2014
Q1
$3.82M Buy
212,237
+33,114
+18% +$614K ﹤0.01% 2196
2013
Q4
$3.51M Buy
179,123
+5,838
+3% +$85.4K ﹤0.01% 2207
2013
Q3
$2.08M Sell
173,285
-131,798
-43% -$1.66M ﹤0.01% 2424
2013
Q2
$3.35M Buy
+305,083
New +$6.43M ﹤0.01% 2104

Other funds holding DVAX

Ameriprise's DVAX Position: Q1 2026 in Review

Ameriprise sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 284,995 shares — an estimated $4.38M sold.

Ameriprise first reported a position in DVAX in Q2 2013 and held it in 50 quarters. The position peaked at $16.6M in Q1 2016. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Ameriprise reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 284,995 Dynavax Technologies shares in Q1 2026, an estimated $4.38M.
  • Ameriprise first reported a position in Dynavax Technologies in Q2 2013 and held it in 50 quarters.
  • Ameriprise's Dynavax Technologies position peaked at $16.6M in Q1 2016.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.